NEW YORK (GenomeWeb) – Fluidigm this week announced the sale of 9,090,909 shares of common stock, which it expects will raise gross proceeds of roughly $30 million before commissions and offering costs.

The company sold the shares through its "at-the-market" equity offering program, which it announced earlier this month.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.